OtherClinical Investigations
Effect of Diabetes Mellitus on Myocardial 18F-FDG SPECT Using Acipimox for the Assessment of Myocardial Viability
Arend F.L. Schinkel, Jeroen J. Bax, Roelf Valkema, Abdou Elhendy, Ron T. van Domburg, Eleni C. Vourvouri, Manolis A. Bountioukos, Eric P. Krenning, Jos R.T.C. Roelandt and Don Poldermans
Journal of Nuclear Medicine June 2003, 44 (6) 877-883;
Arend F.L. Schinkel
Jeroen J. Bax
Roelf Valkema
Abdou Elhendy
Ron T. van Domburg
Eleni C. Vourvouri
Manolis A. Bountioukos
Eric P. Krenning
Jos R.T.C. Roelandt
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 4
April 1, 2024
Effect of Diabetes Mellitus on Myocardial 18F-FDG SPECT Using Acipimox for the Assessment of Myocardial Viability
Arend F.L. Schinkel, Jeroen J. Bax, Roelf Valkema, Abdou Elhendy, Ron T. van Domburg, Eleni C. Vourvouri, Manolis A. Bountioukos, Eric P. Krenning, Jos R.T.C. Roelandt, Don Poldermans
Journal of Nuclear Medicine Jun 2003, 44 (6) 877-883;
Effect of Diabetes Mellitus on Myocardial 18F-FDG SPECT Using Acipimox for the Assessment of Myocardial Viability
Arend F.L. Schinkel, Jeroen J. Bax, Roelf Valkema, Abdou Elhendy, Ron T. van Domburg, Eleni C. Vourvouri, Manolis A. Bountioukos, Eric P. Krenning, Jos R.T.C. Roelandt, Don Poldermans
Journal of Nuclear Medicine Jun 2003, 44 (6) 877-883;
Related Articles
- No related articles found.
Cited By...
- Extent of Viability to Predict Response to Cardiac Resynchronization Therapy in Ischemic Heart Failure Patients
- Nitrate Administration Increases Blood Flow in Dysfunctional but Viable Myocardium, Leading to Improved Assessment of Myocardial Viability: A PET Study
- Effect of Intramyocardial Injection of Autologous Bone Marrow-Derived Mononuclear Cells on Perfusion, Function, and Viability in Patients with Drug-Refractory Chronic Ischemia
- Impact of Diabetes Mellitus on Prediction of Clinical Outcome After Coronary Revascularization by 18F-FDG SPECT in Patients with Ischemic Left Ventricular Dysfunction
- Diabetic cardiomyopathy: mechanisms, diagnosis and treatment
- Reduced Oxidative Metabolic Response in Dysfunctional Myocardium with Preserved Glucose Metabolism but with Impaired Contractile Reserve